Novartis AG buy phonebroker
Start price
30.05.10
/
50%
€37.11
Target price
15.06.10
€44.00
Performance (%)
6.99%
End price
15.06.10
€39.71
Summary
This prediction ended on 15.06.10 with a price of €39.71. With a performance of 6.99%, the BUY prediction by phonebroker for Novartis AG closed with a slight gain. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novartis AG | -4.254% | -4.254% | 24.691% | 63.750% |
| iShares Core DAX® | -0,05 % | 5,96 % | 7,40 % | 65,85 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % | 28,14 % | 93,30 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % | 48,89 % | 89,08 % |
| iShares S&P 500 | -0,36 % | 2,75 % | 22,53 % | 71,94 % |
Comments by phonebroker for this prediction
In the thread Novartis AG diskutieren
Langfristinvestment
Novartis passt in jedes Depot für die Alterssicherung, aber auch in jedes andere.
Gründe: Weltweit drittgrößter Pharmakonzern, dividendenstark, Bilanzierung nicht in EURO